Advisornet Financial’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,495
Closed -$244 2511
2022
Q4
$244 Hold
1,495
﹤0.01% 2181
2022
Q3
$0 Hold
1,495
﹤0.01% 2108
2022
Q2
$0 Sell
1,495
-8,000
-84% -$2.04K ﹤0.01% 2235
2022
Q1
$3K Buy
9,495
+750
+9% +$245 ﹤0.01% 1756
2021
Q4
$3K Buy
8,745
+5,250
+150% +$2.37K ﹤0.01% 1791
2021
Q3
$2K Buy
3,495
+2,000
+134% +$1.18K ﹤0.01% 1787
2021
Q2
$1K Hold
1,495
﹤0.01% 1791
2021
Q1
$2K Buy
+1,495
New +$2.44K ﹤0.01% 1669

Other funds holding ZOM

Advisornet Financial's ZOM Position: Q1 2023 in Review

Advisornet Financial sold out of Zomedica Corp. (ZOM) in Q1 2023, closing a stake of 1,495 shares — an estimated $244 sold.

Advisornet Financial first reported a position in ZOM in Q1 2021 and held it in 8 quarters. The position peaked at $3K in Q1 2022. 90 funds tracked by Wall St. Rank hold ZOM as of Q1 2023.

  • Advisornet Financial reported no remaining Zomedica Corp. position as of Q1 2023 after selling out during the quarter.
  • Advisornet Financial sold 1,495 Zomedica Corp. shares in Q1 2023, an estimated $244.
  • Advisornet Financial first reported a position in Zomedica Corp. in Q1 2021 and held it in 8 quarters.
  • Advisornet Financial's Zomedica Corp. position peaked at $3K in Q1 2022.
  • 90 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2023.

Based on Advisornet Financial's 13F filing for Q1 2023, filed 28 Apr 2023.